# Safety and Efficacy of Cannabis in Tourette Syndrome

> **NCT03247244** · PHASE2 · TERMINATED · sponsor: **University Health Network, Toronto** · enrollment: 15 (actual)

## Conditions studied

- Tourette Syndrome

## Interventions

- **DRUG:** Cannabis
- **DRUG:** Cannabis
- **DRUG:** Cannabis

## Key facts

- **NCT ID:** NCT03247244
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-01-15
- **Primary completion:** 2019-06-06
- **Final completion:** 2020-01-27
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** Recruitment/enrollment took too long
- **Last updated:** 2021-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03247244

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03247244, "Safety and Efficacy of Cannabis in Tourette Syndrome". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03247244. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*